Bristol-Myers Squibb Company (BMY) — Technical state

As of 2026-09-17 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Pullback inside an uptrend stack

Trades -1.7% vs the 50-day and +7.5% vs the 200-day average, 8.4% below the 52-week high and +51.1% off the 52-week low. Computed from daily closes.

The moving-average stack

vs 20-day-4.5%
vs 50-day-1.7%
vs 200-day+7.5%
52-week band8.4% off the high · +51.1% off the low
Streak3 consecutive down sessions
50-day crossprice crossed down through the 50-day 1 sessions ago
Stochastic%K 5.6 · %D 12.3 · bear cross

Continue: the BMY chart & overview · the signal board

FAQ · from the current data · as of 2026-09-17

Quick answers

What is the current Closelook signal on BMY?

Pullback inside an uptrend stack — Trades -1.7% vs the 50-day and +7.5% vs the 200-day average, 8.4% below the 52-week high and +51.1% off the 52-week low. Computed from daily closes. As of 2026-09-17; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BMY above its 50-day and 200-day moving averages?

As of 2026-09-17, Bristol-Myers Squibb Company trades -1.7% below its 50-day and +7.5% above its 200-day average, with the 20-day -4.5% away.

How far is BMY from its 52-week high?

8.4% below the 52-week high and 51.1% above the 52-week low, as of 2026-09-17.

Related in the Closelook universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.